Humana Inc (NYSE:HUM) Shares Sold by Signaturefd LLC

Share on StockTwits

Signaturefd LLC trimmed its position in shares of Humana Inc (NYSE:HUM) by 17.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 360 shares of the insurance provider’s stock after selling 74 shares during the period. Signaturefd LLC’s holdings in Humana were worth $96,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Whittier Trust Co. acquired a new stake in Humana during the 2nd quarter valued at $27,000. Destination Wealth Management grew its holdings in Humana by 130.0% during the 1st quarter. Destination Wealth Management now owns 115 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 65 shares in the last quarter. Advantage Investment Management LLC grew its holdings in Humana by 287.1% during the 2nd quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 89 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Humana during the 2nd quarter valued at $36,000. Finally, Evolution Wealth Advisors LLC acquired a new stake in Humana during the 2nd quarter valued at $46,000. 89.88% of the stock is owned by institutional investors and hedge funds.

Several research analysts have weighed in on HUM shares. ValuEngine raised shares of Humana from a “sell” rating to a “hold” rating in a report on Friday, July 12th. Cantor Fitzgerald raised shares of Humana from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $300.00 to $345.00 in a report on Monday, August 12th. JPMorgan Chase & Co. raised their price objective on shares of Humana from $288.00 to $322.00 and gave the stock an “overweight” rating in a report on Thursday, August 1st. Piper Jaffray Companies raised their price objective on shares of Humana from $315.00 to $341.00 and gave the stock an “overweight” rating in a report on Thursday, August 1st. Finally, Morgan Stanley raised their price objective on shares of Humana from $315.00 to $342.00 and gave the stock an “overweight” rating in a report on Friday, August 23rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company. Humana presently has a consensus rating of “Buy” and a consensus price target of $341.95.

In other news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $289.70, for a total value of $2,097,138.30. Following the transaction, the insider now directly owns 12,994 shares in the company, valued at approximately $3,764,361.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.54% of the company’s stock.

Shares of Humana stock traded down $1.20 during trading hours on Friday, reaching $273.51. The company’s stock had a trading volume of 563,498 shares, compared to its average volume of 902,176. The company’s 50 day simple moving average is $287.76 and its 200 day simple moving average is $270.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.75 and a current ratio of 1.75. Humana Inc has a one year low of $225.65 and a one year high of $355.88. The stock has a market cap of $37.11 billion, a P/E ratio of 18.80, a price-to-earnings-growth ratio of 1.19 and a beta of 0.84.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $5.24 by $0.81. Humana had a net margin of 4.13% and a return on equity of 22.47%. The company had revenue of $16.25 billion for the quarter, compared to the consensus estimate of $15.88 billion. During the same period last year, the firm posted $3.96 EPS. The company’s revenue for the quarter was up 13.9% on a year-over-year basis. On average, sell-side analysts predict that Humana Inc will post 17.63 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a $0.55 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.80%. Humana’s payout ratio is currently 15.12%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: Trading Ex-Dividend

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.